Greenwich LifeSciences, Inc. SEC filings GLSI
Greenwich LifeSciences, Inc. has 279 filings in SEC EDGAR's recent list, going back to Jan 27, 2020. Its latest annual report, Form ARS, was filed on Oct 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Dec 18, 2025 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Dec 20, 2024 | — |
| S-3 | Shelf registration | Oct 7, 2024 | — |
| 424B5 | Prospectus supplement | Jul 12, 2022 | — |
| S-8 | Employee stock plan registration | Jul 5, 2022 | — |
| S-3/A | Filing | Apr 1, 2022 | — |
| S-3 | Shelf registration | Mar 25, 2022 | — |
| 424B3 | Prospectus | Mar 8, 2021 | — |
| 424B4 | Prospectus | Dec 18, 2020 | — |
| S-1MEF | Filing | Dec 17, 2020 | — |
| FWP | Free writing prospectus | Dec 16, 2020 | — |
| S-1 | Registration statement | Dec 15, 2020 | — |
| 424B3 | Prospectus | Nov 10, 2020 | — |
| 424B4 | Prospectus | Sep 28, 2020 | — |
| 424B4 | Prospectus | Sep 28, 2020 | — |
| FWP | Free writing prospectus | Sep 22, 2020 | — |
| S-1/A | Amended registration statement | Sep 10, 2020 | — |
| S-1/A | Amended registration statement | Sep 9, 2020 | — |
| S-1/A | Amended registration statement | Jun 26, 2020 | — |
| FWP | Free writing prospectus | Jun 23, 2020 | — |
| S-1/A | Amended registration statement | Jun 23, 2020 | — |
| S-1 | Registration statement | May 29, 2020 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- GLSI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Stafford, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1799788
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.